Rosetta Stone (RST) PT Raised to $27 at Barrington Research
Get Alerts RST Hot Sheet
Rating Summary:
2 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
Barrington Research analyst Alexander Paris, Jr. raised the price target on Rosetta Stone (NYSE: RST) to $27.00 (from $24.00) while maintaining a Outperform rating.
Analyst says: "We would continue to be buyers of RST given the intrinsic value of its parts; continued strong growth at Lexia, which has been driven by a bookings CAGR of 26% since 2014; a more predictable/sustainable sales model as a result of the subscription transition, which will continue to benefit from sales team alignment as the company executes on its top-down and bottom-up go-to-market strategy; improving cash flow; and its already healthy balance sheet with no long-term debt."
As a reminder, RST reported fourth quarter and full year 2018 results yesterday after market close. Highlights of the earnings release:
Revenue at Lexia Learning ("Lexia"), the Company's Literacy segment, increased 20% year-over-year to a record high $14.5 million.
Revenue within the Consumer Language segment declined 13% year-over-year to $15.5 million. The expected revenue decline reflects the transition to a full subscription model in which revenue is recognized ratably over the subscription period, which was completed in the first quarter 2018. Consumer Lifetime Value (“LTV”) added was $58.9 million in the full year 2018, an increase of 6% from the year-ago period.
Revenue within the Enterprise & Education (“E&E”) Language segment decreased 3% year-over-year to $14.6 million, the lowest year-over-year decline in 6 quarters.
Total operating expenses increased 1% year-over-year, to $39.2 million.
At December 31, 2018 the Company had zero debt outstanding and cash and cash equivalents totaled $38.1 million.
Shares of RST trade up +28.1%, while SPY trades down -0.84% in morning trading.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Outlook Therapeutics Inc. (OTLK) PT Lowered to $4 at Brookline Capital Markets
- Motorcar Parts of America (MPAA) PT Lowered to $16 at Freedom Broker
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share